The United States Judicial Panel on Multidistrict Litigation has issued and order consolidating all federal lawsuits related to defective, double strength Digitek (commonly known as Digitalis or Digoxin ) to the U.S. District Court for the Southern District of West Virginia. Continue reading ⇒
Digitek Recall Facts:
Digitek (digoxin) is the most prescribed medication used to treat congestive heart failure and abnormal heart rhythms in the United States. On April 25, 2008, the drug\'s manufacturer Actavis Toyota, LLC, a U.S. subsidiary of Actavis Group, voluntarily initiated a nationwide recall of Digitek oral tablets of all strengths. Digitek is sold and distributed by two companies, Mylan Pharmaceuticals, Inc. under a "Bertek" label and by UDL Laboratories, Inc. under a "UDL" label.
The recall occurred after it was discovered that as a result of a manufacturing defect, tablets may have been sold in the U.S. market with double the thickness of the normal sized tablets. These flawed Digitek tablets may contain as much as twice the active ingredient. This could mean that patients who take the defective tablets may be exposed to twice the strength of the prescribed dosage.
Potential Effects of Digitek Overdose:
An overdose of Digitek could result in digitalis toxicity. This could be characterized by nausea, vomiting, dizziness, low blood sugar, cardiac instability and bradycardia. In some cases death could result. Actavis Totowa has received numerous reports of illnesses and injuries due to patients who may have taken the defective tablets. .
Cases have been brought against the manufacturer of Digitek on behalf of patients who were injured by the defective pills. Our lawyers are investigating claims and filing lawsuits for individuals who reside in every state across the country. Please fill out the form to the right and your submission will be forwarded to an experienced DrugSettlement.com attorney or representative who will contact you for a free and confidential evaluation.
Lawsuits of Interest
- 1 of 4